Therapeutic potential of antimicrobial peptides in atopic dermatitis
Peter Wolf & Vijay Kumar Patra, Department of Dermatology, Medical University of Graz
Prof. Dr. Peter Wolf|
|Availability:||This position is available.|
Medical University of Graz
|Application deadline:||Applications are accepted between August 14, 2020 00:00 and October 10, 2020 23:59 (Europe/Zurich)|
Atopic dermatitis (AD) is a common inflammatory skin disease with complex etiopathology linked to abnormal inflammatory pathways, and dysbiotic colonization by Staphylococcus aureus (S. aureus). The microbial dysbiosis is related to failure in expressing antimicrobial peptides (AMPs; small peptides bearing microbiocidal and immunomodulatory functions) in the skin. Phototherapy (using different wavebands of UV radiation) is a widely used treatment for moderate to severe AD and is known to decrease cutaneous inflammation with minimal or no systemic side effects. Intriguingly, UV is known to modulate microbial communities and induce certain AMPs in the skin.[3, 4]
Hypothesis and Objectives:
We hypothesize that the efficacy of phototherapy in AD patients depends on the capacity of UV to (re)induce the expression of AMPs from the host skin or microbe, which can normalize the dysbiotic S. aureus colonization. Furthermore, we hypothesize that such AMPs could be used therapeutically to target S. aureus and improve AD symptoms. The primary objectives of the proposed work are to (i) screen the diversity of host- and microbe-associated AMPs and (ii) investigate impact of UV radiation on S. aureus biology in AD patients undergoing phototherapy; (iii) decipher the complex interplay between S. aureus colonization, UV exposure, and AMP expression; (iv) to establish novel therapeutic strategies by reducing the dysbiotic microbiome/colonization with certain AMPs in an S. aureus-induced AD-like mouse models.
Overall, the multidisciplinary and translational nature of this proposed work will involve a combination of microbiology, immunology, bioinformatics, and molecular biology. The PhD candidate will utilize state-of-the-art techniques such as de novo peptide sequencing using mass spectrometry (to detect AMPs), whole genome shotgun sequencing, RNA sequencing, bioinformatics (for AMP database, microbiome analysis and statistics) and biologic samples from patients and pre-clinical models to achieve the objectives.
The PhD candidate will be given the opportunity to design and conduct experiments and to present research results at international scientific meetings.
1. Byrd, A. L., C. Deming, S. K. B. Cassidy, O. J. Harrison, W. I. Ng, S. Conlan, Nisc Comparative Sequencing Program, Y. Belkaid, J. A. Segre, and H. H. Kong. "Staphylococcus Aureus and Staphylococcus Epidermidis Strain Diversity Underlying Pediatric Atopic Dermatitis." Sci Transl Med 9, no. 397 (2017).
2. Patra, V., G. Mayer, A. Gruber-Wackernagel, M. Horn, S. Lembo, and P. Wolf. "Unique Profile of Antimicrobial Peptide Expression in Polymorphic Light Eruption Lesions Compared to Healthy Skin, Atopic Dermatitis, and Psoriasis." Photodermatol Photoimmunol Photomed 34, no. 2 (2018): 137-44.
3. Glaser, R., F. Navid, W. Schuller, C. Jantschitsch, J. Harder, J. M. Schroder, A. Schwarz, and T. Schwarz. "Uv-B Radiation Induces the Expression of Antimicrobial Peptides in Human Keratinocytes in Vitro and in Vivo." J Allergy Clin Immunol 123, no. 5 (2009): 1117-23.
4. Patra, V., K. Wagner, V. Arulampalam, and P. Wolf. "Skin Microbiome Modulates the Effect of Ultraviolet Radiation on Cellular Response and Immune Function." iScience 15 (2019): 211-22.
5. Nakatsuji, T., T. H. Chen, S. Narala, K. A. Chun, A. M. Two, T. Yun, F. Shafiq, P. F. Kotol, A. Bouslimani, A. V. Melnik, H. Latif, J. N. Kim, A. Lockhart, K. Artis, G. David, P. Taylor, J. Streib, P. C. Dorrestein, A. Grier, S. R. Gill, K. Zengler, T. R. Hata, D. Y. Leung, and R. L. Gallo. "Antimicrobials from Human Skin Commensal Bacteria Protect against Staphylococcus Aureus and Are Deficient in Atopic Dermatitis." Sci Transl Med 9, no. 378 (2017).
6. Gamradt, P., L. Laoubi, A. Nosbaum, V. Mutez, V. Lenief, S. Grande, D. Redoules, A. M. Schmitt, J. F. Nicolas, and M. Vocanson. "Inhibitory Checkpoint Receptors Control Cd8(+) Resident Memory T Cells to Prevent Skin Allergy." J Allergy Clin Immunol 143, no. 6 (2019): 2147-57 e9.